Geode Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Buy |
1,361,740
+771,454
| +131% | +$3.09M | ﹤0.01% | 2683 |
|
|
2025
Q1 | $1.88M | Buy |
590,286
+23,423
| +4% | +$74.5K | ﹤0.01% | 3059 |
|
|
2024
Q4 | $3.03M | Buy |
566,863
+3,854
| +0.7% | +$20.6K | ﹤0.01% | 2978 |
|
|
2024
Q3 | $2.97M | Buy |
563,009
+102,869
| +22% | +$543K | ﹤0.01% | 3001 |
|
|
2024
Q2 | $838K | Buy |
460,140
+88,377
| +24% | +$161K | ﹤0.01% | 3377 |
|
|
2024
Q1 | $662K | Buy |
371,763
+11,383
| +3% | +$20.3K | ﹤0.01% | 3517 |
|
|
2023
Q4 | $634K | Hold |
360,380
| – | – | ﹤0.01% | 3525 |
|
|
2023
Q3 | $526K | Buy |
360,380
+18,301
| +5% | +$26.7K | ﹤0.01% | 3586 |
|
|
2023
Q2 | $783K | Buy |
342,079
+44,279
| +15% | +$101K | ﹤0.01% | 3450 |
|
|
2023
Q1 | $271K | Hold |
297,800
| – | – | ﹤0.01% | 3903 |
|
|
2022
Q4 | $253K | Sell |
297,800
-660
| -0.2% | -$561 | ﹤0.01% | 3966 |
|
|
2022
Q3 | $244K | Hold |
298,460
| – | – | ﹤0.01% | 4088 |
|
|
2022
Q2 | $295K | Hold |
298,460
| – | – | ﹤0.01% | 4036 |
|
|
2022
Q1 | $489K | Buy |
298,460
+13,586
| +5% | +$22.3K | ﹤0.01% | 3943 |
|
|
2021
Q4 | $686K | Buy |
284,874
+74,631
| +35% | +$180K | ﹤0.01% | 3884 |
|
|
2021
Q3 | $1.02M | Buy |
210,243
+20,702
| +11% | +$100K | ﹤0.01% | 3663 |
|
|
2021
Q2 | $506K | Buy |
189,541
+40,707
| +27% | +$109K | ﹤0.01% | 3940 |
|
|
2021
Q1 | $458K | Buy |
148,834
+38,174
| +34% | +$117K | ﹤0.01% | 3848 |
|
|
2020
Q4 | $393K | Sell |
110,660
-888
| -0.8% | -$3.15K | ﹤0.01% | 3671 |
|
|
2020
Q3 | $447K | Sell |
111,548
-32,814
| -23% | -$131K | ﹤0.01% | 3458 |
|
|
2020
Q2 | $392K | Buy |
144,362
+5,446
| +4% | +$14.8K | ﹤0.01% | 3455 |
|
|
2020
Q1 | $293K | Buy |
138,916
+1,361
| +1% | +$2.87K | ﹤0.01% | 3436 |
|
|
2019
Q4 | $748K | Buy |
137,555
+8,198
| +6% | +$44.6K | ﹤0.01% | 3373 |
|
|
2019
Q3 | $389K | Buy |
129,357
+14,563
| +13% | +$43.8K | ﹤0.01% | 3557 |
|
|
2019
Q2 | $429K | Sell |
114,794
-48,097
| -30% | -$180K | ﹤0.01% | 3519 |
|
|
2019
Q1 | $654K | Buy |
162,891
+10,530
| +7% | +$42.3K | ﹤0.01% | 3326 |
|
|
2018
Q4 | $559K | Buy |
152,361
+24,322
| +19% | +$89.2K | ﹤0.01% | 3333 |
|
|
2018
Q3 | $1.1M | Buy |
128,039
+4,686
| +4% | +$40.2K | ﹤0.01% | 3182 |
|
|
2018
Q2 | $1.35M | Buy |
123,353
+47,391
| +62% | +$520K | ﹤0.01% | 3057 |
|
|
2018
Q1 | $875K | Buy |
75,962
+1,963
| +3% | +$22.6K | ﹤0.01% | 3185 |
|
|
2017
Q4 | $766K | Buy |
73,999
+626
| +0.9% | +$6.48K | ﹤0.01% | 3204 |
|
|
2017
Q3 | $1.17M | Buy |
73,373
+4,599
| +7% | +$73.3K | ﹤0.01% | 3054 |
|
|
2017
Q2 | $832K | Buy |
68,774
+28,224
| +70% | +$341K | ﹤0.01% | 3174 |
|
|
2017
Q1 | $842K | Buy |
40,550
+2,570
| +7% | +$53.4K | ﹤0.01% | 3104 |
|
|
2016
Q4 | $543K | Buy |
37,980
+1,095
| +3% | +$15.7K | ﹤0.01% | 3237 |
|
|
2016
Q3 | $606K | Buy |
+36,885
| New | +$606K | ﹤0.01% | 3175 |
|